Previous 10 | Next 10 |
Invitae, UCL and the Francis Crick Institute Announce New Data From TRACERx Research Collaboration at the 2021 International Society of Liquid Biopsy Congress -- Study uses Invitae Personalized Cancer Monitoring (PCM™) liquid biopsy to accurately profile tumors and enhanc...
The stock portfolio performance has remained relatively flattish in the wake of the collapse described in the previous portfolio update, and remains substantially down YTD. I have further diversified the portfolio with a few more well known best-of-breed tech stocks. I also bought a n...
Baker Brothers’ 13F portfolio value decreased from $23.07B to $22.77B this quarter. The InVitae stake was reduced this quarter while increasing Apellis Pharma and Heron Therapeutics. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almo...
What do the world's most confident investors do when their favorite stocks dive along with the rest of the stock market? If you're Cathie Wood, the CEO and founder of ARK Invest you do some bargain shopping. Rising interest rates in the U.S. and a financial crisis in China have been dri...
New Study Highlights the Value of Genetic Testing to Guide Clinical Management and Improve Outcomes for Epilepsy Patients -- Study finds improved seizure control and positive outcomes in 75 percent of patients with actionable genetic findings that led to clinical management chan...
EXAS continued to grow its top line revenue at a 62 percent year over year rate in Q2. However, this resulted in a deteriorating bottom line of -$176.9 million. Another possibility for dilution is the rumoured merger between EXAS and NVTA. Shift in demand as a result of the widesp...
The following slide deck was published by Invitae Corporation in conjunction with this event. For further details see: Invitae (NVTA) Presents At Ciitizen Announcement Conference Call Presentation - Slideshow
What do the most successful investors do when their favorite stocks tank? If you're Cathie Wood, founder, and CEO of ARK Invest, you keep buying more. Shares of life-science equipment manufacturer Berkeley Lights (NASDAQ: BLI) took a hit last week, and two ARK Invest ETFs qu...
Invitae Corporation (NVTA) Morgan Stanley 19th Annual Global Healthcare Conference September 14, 2021, 12:30 PM ET Company Participants Tejas Savant - VP, Senior Healthcare Equity Analyst Conference Call Participants Sean George - CEO Roxi Wen - CFO Presentation Tejas Savant Okay everyone. Th...
CAMBRIDGE, United Kingdom, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Dante Labs , a global leader in genomics and precision medicine, today announced the appointments of Andre Nel, Dalila Rahmani, Laura D’Angelo and Omar Elbakshish to the company’s management team, expanding ...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...